Geratherm Medical AG
Important Dates
Geratherm Medical AG's next confirmed earnings release is scheduled for April 27, 2027.
| Earnings Date | 4/27/2027 |
Share Statistics
As of June 30, 2023, Geratherm Medical AG has 5.43M shares outstanding.
| Shares Outstanding | 5.43M |
Financial Position
As of June 30, 2023, Geratherm Medical AG maintains a current ratio of 13.99, meaning it holds 14.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 13.99 |
| Quick Ratio | 6.47 |
| Debt / Equity | 35.05 |
Taxes
EUROver the twelve months ended June 30, 2023, Geratherm Medical AG recorded 492,518.00 in income tax expense.
| Income Tax | 492,518.00 |
Stock Price Statistics
EURAs of the close on September 30, 2026, Geratherm Medical AG's stock has declined approximately 35.71% over the past 52 weeks.
| 52-Week Price Change | -35.71% |
| 50-Day Moving Average | 3.60 |
Balance Sheet
EURAs of June 30, 2023, Geratherm Medical AG holds 10.90M in cash and equivalents against 8.15M in total debt, resulting in a net debt position of -571,590.00. Total book value stands at 22.84M, with working capital of 21.88M providing operational flexibility.
| Cash & Cash Equivalents | 10.90M |
| Total Debt | 8.15M |
| Net Debt | -571,590.00 |
| Equity (Book Value) | 22.84M |
| Book Value Per Share | 4.21 |
| Working Capital | 21.88M |
Cash Flow
EURThese figures cover the twelve months ended June 30, 2023.
| Capital Expenditures | 55,000.00 |